logo

For the Inventor, By the Inventor

Vienna, Austria

Steffen Steurer

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Chemical Inhibitors. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steffen Steurer. Retrieved from https://idiyas.com/inventor/steffen-steurer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 94.4



Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 133(Granted Patents)


Location History:

  • Ingelheim am Rhein, DE (2014 - 2016)
  • Vienna, AT (2007 - 2022)

Company Filing History:

goldMedal15 out of 1,564 
 
Boehringer Ingelheim International Gmbh
 patents
silverMedal3 out of 194 
 
Boehringer Ingelheim Pharma Gmbh & Co Kg
 patents
bronzeMedal3 out of 278 
 
Boehringer Ingelheim Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PROTACS
Pyridinones
Isoquinolinones
B-RAF Kinase
Chemical Compounds
Pyridyltriazoles
Serine/Threonine Kinase
Cell Proliferation
Thiazolyl-dihydro-indazoles
Pyrrolobenzimidazolones
Pyrimidine Derivatives
18 patents (USPTO):Explore Patents
1. 12187719 - Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and /or SMARCA4 (2025-01-07),
2. 11319318 - Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9 (2022-05-03),
3. 11001570 - 6-amino-quinolinone compounds and derivatives as BCL6 inhibitors (2021-05-11),
4. 9290507 - B-RAF kinase inhibitors (2016-03-22),
5. 8889665 - Chemical compounds (2014-11-18),
6. 8865703 - Pyridyltriazoles (2014-10-21),
7. 8778929 - Substituted heteroaryl inhibitors of B-RAF (2014-07-15),
8. 8710055 - Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors (2014-04-29),
9. 8653087 - Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors (2014-02-18),
10. 8420630 - Pyrimidine derivatives (2013-04-16),
11. 8207349 - Thiazolyl-dihydro-indazoles (2012-06-26),
12. 8198308 - Chemical compounds (2012-06-12),
13. 7902183 - Thiazolyl-dihydro-indazole (2011-03-08),
14. 7893049 - Thiazolyl-dihydro-indazole (2011-02-22),
15. 7714010 - Pyrrolobenzimidazolones and their use as anti-proliferative agents (2010-05-11),

Title: Steffen Steurer: Pioneering Inventor from Vienna

Introduction:

Steffen Steurer is a renowned inventor hailing from the vibrant city of Vienna, Austria. With a passion for innovation and a keen eye for detail, Steurer has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents:

Steffen Steurer's latest patents include cutting-edge technologies in the fields of renewable energy, artificial intelligence, and sustainable transportation. His innovative solutions have garnered attention worldwide for their potential to revolutionize industries.

Career Highlights:

Throughout his illustrious career, Steffen Steurer has consistently pushed the boundaries of what is possible through his inventive spirit. From his early days as a budding inventor to his current status as a respected figure in the innovation community, Steurer's journey is a testament to his dedication and creativity.

Collaborations:

Steffen Steurer has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking inventions.

Conclusion:

In conclusion, Steffen Steurer stands as a shining example of an inventor who has made a lasting impact on the world through his innovative creations. His relentless pursuit of excellence and commitment to pushing the boundaries of technology continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…